Suchergebnisse - "Bastida, Carla"

PubPharm (36)

1

Tocilizumab Dose Tapering Based on a Model-Based Algorithm is Feasible in Clinical Practice : A Short Communication

enthalten in: Therapeutic drug monitoring | 2024

von Hooijberg, F. | Layegh, Z. | Leeuw, M. | +12

2

Predictive performance of glomerular filtration rate equations based on cystatin C, creatinine and their combination in critically ill patients

enthalten in: European journal of hospital pharmacy : science and practice | 2023

von Albanell-Fernández, M. | Bastida, C. | Marcos Fendian, �. | +3

3

Creatine Kinase Elevation in Autosomal Dominant Polycystic Kidney Disease Patients on Tolvaptan Treatment

enthalten in: Nephron | 2023

von Rodríguez-Espinosa, D. | Broseta, J. | Bastida, C. | +12

4

Use of insulin and heparin in the management of severe hypertriglyceridemia in a critically ill patient

enthalten in: Medicina clinica | 2022

von Arranz, N. | Fernández, S. | Bastida, C.

5

Tigecycline population pharmacokinetics in critically ill patients with decompensated cirrhosis and severe infections

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Bastida, C. | Hernández-Tejero, M. | Cariqueo, M. | +6

6

Is there a potential for therapeutic drug monitoring of subcutaneously administered tocilizumab in patients with rheumatoid arthritis in daily practice?

enthalten in: Clinical and experimental rheumatology | 2022

von Layegh, Z. | Hooijberg, F. | Bastida, C. | +3

CommentOn: Scand J Rheumatol. 2017 Mar;46(2):87-94. - PMID 27440258

7

Once-daily 1 g ceftriaxone optimizes exposure in patients with septic shock and hypoalbuminemia receiving continuous veno-venous hemodiafiltration

enthalten in: European journal of clinical pharmacology | 2021

von Ulldemolins, M. | Bastida, C. | Llauradó-Serra, M. | +5

8

Once-daily 1 g ceftriaxone optimizes exposure in patients with septic shock and hypoalbuminemia receiving continuous veno-venous hemodiafiltration

enthalten in: European journal of clinical pharmacology | 2021

von Ulldemolins, M. | Bastida, C. | Llauradó-Serra, M. | +5

9

Once-daily 1 g ceftriaxone optimizes exposure in patients with septic shock and hypoalbuminemia receiving continuous veno-venous hemodiafiltration

enthalten in: European journal of clinical pharmacology | 2021

von Ulldemolins, M. | Bastida, C. | Llauradó-Serra, M. | +5

10

Once-daily 1 g ceftriaxone optimizes exposure in patients with septic shock and hypoalbuminemia receiving continuous veno-venous hemodiafiltration

enthalten in: European journal of clinical pharmacology | 2021

von Ulldemolins, M. | Bastida, C. | Llauradó-Serra, M. | +5